V R Prasad
Overview
Explore the profile of V R Prasad including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
41
Citations
551
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Prasad V, Srinivas T, Sarma V
Mar Pollut Bull
. 2015 May;
95(1):115-25.
PMID: 25934433
In order to examine the influence of discharge from different rivers from peninsular India and urban sewage on intensity and dissemination of heterotrophic, indicator and pathogenic bacteria, a study was...
2.
Bailey M, Khaiyum E, Prasad V
Pac Health Dialog
. 2008 Jan;
13(2):151-4.
PMID: 18181406
The Fiji School of Medicine (FSM) has been delivering pharmacy education since 1944. The philosophy of education provision changed from pharmacy technician training to pharmacist education in 1991 and since...
3.
Joshi P, Fisher T, Prasad V
Curr Drug Targets Infect Disord
. 2004 Feb;
3(4):383-400.
PMID: 14754437
The development of resistance and the inability of currently approved antiretroviral drugs to completely eradicate HIV-1 have led to increased focus on therapies other than small molecules. Although nucleic acid-based...
4.
Rezende L, Kew Y, Prasad V
J Biomed Sci
. 2001 Apr;
8(2):197-205.
PMID: 11287751
We previously reported that two insertions of 15 amino acids in the beta3-beta4 hairpin loop of fingers subdomain of HIV-1(NL4-3) RT confer an increased polymerase processivity. The processivity of human...
5.
Shah F, Curr K, Hamburgh M, Parniak M, Mitsuya H, Arnez J, et al.
J Biol Chem
. 2000 Jun;
275(35):27037-44.
PMID: 10833521
Human immunodeficiency virus type 1 (HIV-1) reverse transcriptase (RT) variants with the K65R or L74V substitution display resistance to several nucleoside analogs. An in vitro dNTP exclusion assay revealed an...
6.
Lin J, Makris A, McMahon C, BEAR S, Patriotis C, Prasad V, et al.
J Biol Chem
. 1999 May;
274(21):14706-15.
PMID: 10329666
Tvl-1 is a 269-amino acid ankyrin repeat protein expressed primarily in thymus, lung, and testes that was identified by screening a murine T-cell two-hybrid cDNA library for proteins that associate...
7.
Hamburgh M, Drosopoulos W, Prasad V
Nucleic Acids Res
. 1998 Sep;
26(19):4389-94.
PMID: 9742239
Two nucleoside analog resistance mutations in HIV-1 reverse transcriptase (RT), E89G and M184V, were previously shown to increase the dNTP insertion fidelity of HIV-1 RT. However, forward mutation assays using...
8.
Drosopoulos W, Rezende L, Wainberg M, Prasad V
J Mol Med (Berl)
. 1998 Sep;
76(9):604-12.
PMID: 9725762
Human immunodeficiency virus (HIV) infections are characterized by a high degree of viral variation. The genetic variation is thought to be a combined effect of a high error rate of...
9.
Rezende L, Drosopoulos W, Prasad V
Nucleic Acids Res
. 1998 Jun;
26(12):3066-72.
PMID: 9611256
A common target for therapies against human immuno-deficiency virus type 1 (HIV-1) is the viral reverse transcriptase (RT). Treatment with the widely used nucleoside analog (-)-2', 3'-deoxy-3'-thiacytidine (3TC) leads to...
10.
Drosopoulos W, Prasad V
J Virol
. 1998 Apr;
72(5):4224-30.
PMID: 9557711
Nucleoside analog-resistant variants of human immunodeficiency virus type 1 (HIV-1) reverse transcriptase (RT) that displayed higher in vitro polymerase fidelity were previously identified via nucleotide insertion and mispair extension assays....